ACAT2 and nonpapillary renal cell carcinoma: ACAT2 is an enzyme involved in lipid metabolism, which has been reported to be inversely correlated with the prognosis of ccRCC patients, whereas the underlying mechanism of ACAT2 in ccRCC remains unclear (Zhao et al., 2016).